ABVC BioPharma
ABVC
ABVC
4 hedge funds and large institutions have $1.17M invested in ABVC BioPharma in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.02M |
Top Sellers
| 1 |
VF
1
Virtu Financial
New York
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$3K |
| 3 |
3
Morgan Stanley
New York
|
$4K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $1.02M | 375,142 | +2,382 | +0.6% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $136K | 49,915 | – | – |
|
|
3
Morgan Stanley
New York
| $4K | 1,460 | -26 | -2% |
|
|
4
UBS Group
Zurich,
Switzerland
| $3K | 1,274 | -6,386 | -83% |
|
|
VF
5
Virtu Financial
New York
| – | – | -27,221 | Closed |
|
|
CFGS
6
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|